These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 11354395

  • 1. Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000.
    Drake WM, Kendler DL, Brown JP.
    Clin Ther; 2001 Apr; 23(4):620-6. PubMed ID: 11354395
    [Abstract] [Full Text] [Related]

  • 2. Risedronate: a new oral bisphosphonate.
    Umland EM, Boyce EG.
    Clin Ther; 2001 Sep; 23(9):1409-21. PubMed ID: 11589256
    [Abstract] [Full Text] [Related]

  • 3. [Paget's disease and its therapeutic management].
    Orcel P, Rousière M.
    Presse Med; 2005 Apr 23; 34(8):612-6. PubMed ID: 15962504
    [Abstract] [Full Text] [Related]

  • 4. A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group.
    Miller PD, Brown JP, Siris ES, Hoseyni MS, Axelrod DW, Bekker PJ.
    Am J Med; 1999 May 23; 106(5):513-20. PubMed ID: 10335722
    [Abstract] [Full Text] [Related]

  • 5. Bisphosphonates for Paget's disease of bone in adults.
    Corral-Gudino L, Tan AJ, Del Pino-Montes J, Ralston SH.
    Cochrane Database Syst Rev; 2017 Dec 01; 12(12):CD004956. PubMed ID: 29192423
    [Abstract] [Full Text] [Related]

  • 6. Bisphosphonates for osteoporosis.
    Drug Ther Bull; 2001 Sep 01; 39(9):68-72. PubMed ID: 11586803
    [Abstract] [Full Text] [Related]

  • 7. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP, Ward LC, Stewart GO, Will RK, Criddle RA, Prince RL, Stuckey BG, Dhaliwal SS, Bhagat CI, Retallack RW, Kent GN, Drury PJ, Vasikaran S, Gutteridge DH.
    Bone; 2004 Apr 01; 34(4):747-54. PubMed ID: 15050907
    [Abstract] [Full Text] [Related]

  • 8. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
    Roux C, Gennari C, Farrerons J, Devogelaer JP, Mulder H, Kruse HP, Picot C, Titeux L, Reginster JY, Dougados M.
    Arthritis Rheum; 1995 Jun 01; 38(6):851-8. PubMed ID: 7779130
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of drugs for Paget's disease of bone.
    Reginster JY, Lecart MP.
    Bone; 1995 Nov 01; 17(5 Suppl):485S-488S. PubMed ID: 8573423
    [Abstract] [Full Text] [Related]

  • 10. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
    Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D.
    N Engl J Med; 2005 Sep 01; 353(9):898-908. PubMed ID: 16135834
    [Abstract] [Full Text] [Related]

  • 11. Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
    Siris ES, Lyles KW, Singer FR, Meunier PJ.
    J Bone Miner Res; 2006 Dec 01; 21 Suppl 2():P94-8. PubMed ID: 17229018
    [Abstract] [Full Text] [Related]

  • 12. Modern therapy for Paget's disease of bone: focus on bisphosphonates.
    Devogelaer JP.
    Treat Endocrinol; 2002 Dec 01; 1(4):241-57. PubMed ID: 15799218
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Two cases of monostotic Paget's disease: effects of bisphosphonate.
    Hoshiro M, Harada T, Iwai H, Miyatake T, Nishimura A, Ohno Y, Aoki N.
    Endocr J; 2003 Aug 01; 50(4):385-92. PubMed ID: 14599111
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Paget's disease of bone: a survey of clinical practice in Australia.
    Walsh JP, Attewell R, Stuckey BG, Hooper MJ, Wark JD, Fletcher S, Ferrari V, Eisman JA.
    Bone; 2008 Jun 01; 42(6):1219-25. PubMed ID: 18353737
    [Abstract] [Full Text] [Related]

  • 17. Bisphosphonate therapy.
    Licata AA.
    Am J Med Sci; 1997 Jan 01; 313(1):17-22. PubMed ID: 9001162
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
    Rendina D, Mossetti G, Viceconti R, Sorrentino M, Nunziata V.
    Calcif Tissue Int; 2004 Sep 01; 75(3):189-96. PubMed ID: 15148558
    [Abstract] [Full Text] [Related]

  • 20. Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy.
    Peris P, Alvarez L, Vidal S, Martínez MA, Monegal A, Guañabens N.
    Clin Exp Rheumatol; 2007 Sep 01; 25(2):206-10. PubMed ID: 17543143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.